Article
Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation.
ACS chemical biology - 20 Nov 2015
Fox Jamie C, Tyler Robert C, Guzzo Christina, Tuinstra Robbyn L, Peterson Francis C, Lusso Paolo, Volkman Brian F
Abstract excerpt
Unlike other chemokines, XCL1 undergoes a distinct metamorphic interconversion between a canonical monomeric chemokine fold and a unique β-sandwich dimer. The monomeric conformation binds and activates the receptor XCR1, whereas the dimer binds extracellular matrix glycosaminoglycans and has been associated with anti-human immunodeficiency virus (HIV) activity. Functional studies of WT-XCL1 are complex, as both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
